|
Re: Standard of Care in BETonMACE
|
|
Resverlogix Corp.
|
Mar 19, 2019 09:04AM
|
|
Re: ACC 2019 Abstracts
|
2
|
Resverlogix Corp.
|
Mar 19, 2019 02:45PM
|
|
Re: Vacepa new
|
3
|
Resverlogix Corp.
|
Mar 19, 2019 04:01PM
|
|
Re: Happy Anniversary
|
2
|
Resverlogix Corp.
|
Mar 20, 2019 08:53AM
|
|
Re: Happy Anniversary
|
1
|
Resverlogix Corp.
|
Mar 20, 2019 03:04PM
|
|
Re: Happy Anniversary
|
1
|
Resverlogix Corp.
|
Mar 20, 2019 03:18PM
|
|
Re: Biogen/Eisai Scrap Aducanumab
|
2
|
Resverlogix Corp.
|
Mar 21, 2019 03:07PM
|
|
Are there any levels tested that both placebo and treatment group could get improvement on
|
1
|
Resverlogix Corp.
|
Mar 21, 2019 03:58PM
|
|
5 point MACE
|
3
|
Resverlogix Corp.
|
Mar 22, 2019 07:40AM
|
|
Re: Doing up another Seeking Alpha Post....
|
2
|
Resverlogix Corp.
|
Mar 22, 2019 02:50PM
|
|
Re: Biogen/Eisai Scrap Aducanumab
|
2
|
Resverlogix Corp.
|
Mar 25, 2019 10:18AM
|
|
What is amazing is the size the Chronic Kidney disease market,...
|
5
|
Resverlogix Corp.
|
Mar 25, 2019 10:26AM
|
|
Re: Biogen/Eisai Scrap Aducanumab
|
2
|
Resverlogix Corp.
|
Mar 25, 2019 12:48PM
|
|
Re: What is amazing is the size the Chronic Kidney disease market,...
|
|
Resverlogix Corp.
|
Mar 25, 2019 04:59PM
|
|
Re: Draft of my SA blog post, comments please.
|
2
|
Resverlogix Corp.
|
Mar 25, 2019 06:10PM
|
|
Re: What is amazing is the size the Chronic Kidney disease market,...
|
4
|
Resverlogix Corp.
|
Mar 26, 2019 08:27AM
|
|
Re: Goodbye March, Hello April
|
2
|
Resverlogix Corp.
|
Mar 26, 2019 10:44AM
|
|
Re: Goodbye March, Hello April
|
2
|
Resverlogix Corp.
|
Mar 26, 2019 02:00PM
|
|
Re: Resverlogix Announces Ninth Positive DSMB Recommendation for Phase 3 Study of Apabetalone
|
1
|
Resverlogix Corp.
|
Mar 27, 2019 12:32PM
|
|
Re: DECLARE TIMI-58 w/ prior MI as BETonMACE proxy?
|
2
|
Resverlogix Corp.
|
Mar 28, 2019 01:18PM
|
